Author Details

Georgiev, G. P.

Issue Section Title File
Vol 510, No 1 (2023) Articles MODULAR NANOTRANSPORTERS CAPABLE OF BINDING WITH SARS-COV-2 VIRUS NUCLEOCAPSID PROTEIN INTO TARGET CELLS
Vol 509, No 1 (2023) Articles INTRACELLULAR DELIVERY OF ANTIBODY-LIKE MOLECULE, CAPABLE TO INHIBIT C-MYC
Vol 509, No 1 (2023) Articles SELECTION OF AN AMINO ACID SITE WITH ONE OF THE FASTEST CLEAVAGE KINETICS BY THE ENDOSOMAL PROTEASE CATHEPSIN B FOR POTENTIAL USE IN DRUG DELIVERY SYSTEMS
Vol 515, No 1 (2024) Articles Quantitative description of the N-protein of the SARS-CoV-2 virus degradation in cells stably expressing it under the influence of new modular nanotransporters
Vol 515, No 1 (2024) Articles Modular nanotransporters capable of cause intracellular degradation of the N-protein of the SARS-CoV-2 virus in A549 cells with temporary expression of this protein fused with the fluorescent protein mRuby3
Vol 514, No 1 (2024) Articles HSPBP1 in complex with the peptide of the innate immunity protein TAG7 is able to lyse tumor cells carrying TNFR1 receptor
Vol 520, No 1 (2025) Articles GALA3-containing modular nanotransporters are capable of delivering Keap1 monobody to target cells and inhibiting the formation of reactive oxygen species in the cells
Vol 521, No 1 (2025) Articles Optimization of A549 cell transfection efficiency with a plasmid encoding the N-protein of the SARS-COV-2 virus
Vol 521, No 1 (2025) Articles Increasing the accumulation of modular nanotransporters in mouse tumors by attaching polyethylene glycol to these nanotransporters with the possibility of its release into the tumors
Vol 521, No 1 (2025) Articles Modular nanotransporters containing Keap1 monobodies are capable of reducing the toxic effect of acetaminophen on the liver of mice